Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $328M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CDXS | CODEXIS INC | 1,350,000 | $24.88M | 7.6% | $3.21 | +500.5% | COM | 192005106 |
| — | HARROW HEALTH | 2,210,000 | $19.23M | 5.9% | $4.09 | — | COM | 45323A201 |
| AXGN | AXOGEN INC | 900,000 | $17.82M | 5.4% | $3.33 | +543.4% | COM | 05463X106 |
| — | EPIZYME INC | 1,365,000 | $17.13M | 5.2% | $8.49 | — | COM | 29428V104 |
| QURE | UNIQURE NV | 205,000 | $16.02M | 4.9% | $44.67 | +42.6% | SHS | N90064101 |
| — | ODONATE THERAPEUTICS INC | 425,000 | $15.59M | 4.8% | $24.62 | — | COM | 676079106 |
| OCUL | OCULAR THERAPEUTIX INC | 2,950,000 | $12.98M | 4.0% | $3.91 | -5.2% | COM | 67576A100 |
| — | AMARIN CORP PLC | 645,000 | $12.51M | 3.8% | $3.50 | — | SPONSORED ADR | 023111206 |
| — | BLUEPRINT MEDICINES CORP | 125,000 | $11.79M | 3.6% | $27.77 | — | COM | 09627Y109 |
| — | CERECOR INC | 2,185,536 | $11.18M | 3.4% | $2.99 | — | COM | 15671L109 |
| — | AUDENTES THERAPEUTICS INC | 280,000 | $10.6M | 3.2% | $26.09 | — | COM | 05070R104 |
| PTCT | PTC THERAPEUTICS INC | 226,388 | $10.19M | 3.1% | $28.36 | +39.2% | COM | 69366J200 |
| — | CYTOKINETICS | 900,000 | $10.13M | 3.1% | $8.27 | — | COM NEW | 23282W905 |
| TGTX | TG THERAPEUTICS INC | 1,150,000 | $9.948M | 3.0% | $7.37 | +2.6% | COM | 88322Q108 |
| — | EIDOS THERAPEUTICS INC | 305,550 | $9.496M | 2.9% | $21.64 | — | COM | 28249H104 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,480,000 | $9.309M | 2.8% | $5.99 | 0.0% | COM NEW | 528872302 |
| ETON | ETON PHARMACEUTICALS INC | 1,075,000 | $8.493M | 2.6% | $6.79 | +14.4% | COM | 29772L108 |
| — | MAGENTA THERAPEUTICS INC | 535,000 | $7.891M | 2.4% | $13.22 | — | COM | 55910K108 |
| — | TRICIDA INC | 195,000 | $7.695M | 2.3% | $31.08 | — | COM | 89610F101 |
| — | DECIPHERA PHARMACEUTICALS IN | 310,000 | $6.991M | 2.1% | $22.57 | — | COM | 24344T101 |
| — | FIBROGEN INC | 150,000 | $6.777M | 2.1% | $26.18 | — | COM | 31572Q808 |
| — | BIOHAVEN PHARMACEUTICAL HLDG | 150,000 | $6.569M | 2.0% | $43.79 | — | COM | G11196105 |
| — | CHIMERIX INC | 1,470,000 | $6.35M | 1.9% | $4.07 | — | COM | 16934W106 |
| XOMA | XOMA CORP DEL | 400,000 | $5.944M | 1.8% | $8.03 | +86.9% | COM NEW | 98419J206 |
| — | AVENUE THERAPEUTICS INC | 930,000 | $5.859M | 1.8% | $5.31 | — | COM NEW | 05360L205 |
| IRWD | IRONWOOD PHARMACEUTICAL INC | 525,400 | $5.748M | 1.8% | $11.20 | 0.0% | COM CLASS A | 46333X108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 200,000 | $5.346M | 1.6% | $15.92 | +60.4% | COM | 004225108 |
| ARVN | ARVINAS INC | 220,000 | $4.838M | 1.5% | $21.02 | 0.0% | COM | 04335A105 |
| — | VERMILLION INC | 4,250,000 | $3.783M | 1.2% | $0.89 | — | COM NEW | 92407M206 |
| — | ZYMEWORKS INC | 170,000 | $3.744M | 1.1% | $19.65 | — | COM | 98985W102 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,140,000 | $3.568M | 1.1% | $4.28 | — | COM | G85347105 |
| — | FORTRESS BIOTECH INC | 2,365,000 | $3.548M | 1.1% | $1.74 | — | COM | 034960Q19 |
| VKTX | VIKING THERAPEUTICS INC | 400,000 | $3.32M | 1.0% | $4.57 | +86.9% | COM | 92686J106 |
| — | AIMMUNE THERAPEUTICS INC | 130,000 | $2.708M | 0.8% | $23.78 | — | COM | 00900T107 |
| AQST | AQUESTIVE THERAPEUTICS INC | 590,000 | $2.478M | 0.8% | $5.12 | 0.0% | COM | 03843E104 |
| — | SYNTHORX INC | 157,600 | $2.129M | 0.6% | $15.25 | — | COM | 87167A103 |
| — | RA PHARMACEUTICALS INC | 51,000 | $1.534M | 0.5% | $30.08 | — | COM | 74933V108 |
| FENC | FENNEC PHARMACEUTICALS INC | 295,000 | $1.18M | 0.4% | $10.08 | -58.0% | COM | 31447P100 |
| — | ARQULE INC | 100,000 | $1.101M | 0.3% | $11.01 | — | COM | 04269E107 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 36,000 | $900K | 0.3% | $24.58 | +0.8% | COM | 22663K107 |
| — | PROTALIX BIOTHERAPEUTICS INC | 1,000,000 | $469K | 0.1% | $0.47 | — | COM | 74365A101 |
| — | AZURRX BIOPHARMA INC | 145,000 | $247K | 0.1% | $1.70 | — | COM | 05502L105 |
| — | BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019) | 250,000 | $91,000 | 0.0% | $1426.15 | — | SPONSORED ADR | 09071M106 |